Health / Medical Topics |
Annamycin Liposomal
A liposome-encapsulated form of the semi-synthetic doxorubicin analogue annamycin with antineoplastic activity. Annamycin intercalates into DNA and inhibits topoisomerase II, resulting in the inhibition of DNA replication and repair and RNA and protein synthesis. This agent circumvents multidrug-resistance (MDR) transporters, including P-glycoprotein (P-gp). Liposomal annamycin is less toxic and shows improved antitumor activity compared to annamycin. (NCI Thesaurus)
YOU MAY ALSO LIKE
A substance that is being studied in the treatment of cancer. It belongs to the family of drugs called anthracycline antibiotics. …
The Ann Arbor system classifies lymphoma into four stages based on anatomic lymph nodal group involvement. Disease confined to one nodal group…
The hydrochloride salt form of anlotinib, a receptor tyrosine kinase (RTK) inhibitor with potential antineoplastic and anti-angiogenic activities. Upon administration, anlotininib targets…
Human ANLN wild-type allele is located within 7p15-p14 and is approximately 64 kb in length. This allele, which encodes actin-binding protein anillin,…
This gene is involved in cytokinesis.
An aggressive (fast-growing) disease in which too many myeloblasts (immature white blood cells that are not lymphoblasts) are found in the bone…